Mutations and variations of KISS1 are increasingly detected via GWAS and targeted sequencing approaches; case reports suggest an expected response to GnRHa therapy of CPP in which variations of KISS1 are pathogenic. This evidence concerns the gene KISS1 and central precocious puberty.